Company / Book Value per Share
BioMarin Pharmaceutical Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$31.654
FY2025
5-year range
$23.471 / $31.654
FY2021-FY2025
Trend
+6.7%
vs FY2024
Sector context
#14 of 209
Health Care
What the data says
Among 209 Health Care companies, BioMarin Pharmaceutical is in the top 7% for book value per share. Book Value per Share has increased for 8 consecutive years, from $15.972 in FY2017 to $31.654 in FY2025.
Based on SEC 10-K filings.
$31.654 in FY2025 with a 5-year CAGR of +7.0%. Top quartile in the Health Care sector.
Improved from $26.254 to $31.654 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +8.6%
- 5-Year CAGR
- +7.0%
- 10-Year CAGR
- -
Sector benchmark
-83.3% below sector average
Key checks
Key Insights
- BioMarin Pharmaceutical's book value per share has grown for 8 consecutive years.
- 5-year CAGR of +7.0%, indicating consistent growth.
- In FY2025, book value per share increased 6.7% year-over-year.
- Ranks #14 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $31.654 | +6.7% |
| FY2024 | $29.66 | +13.0% |
| FY2023 | $26.254 | +6.2% |
| FY2022 | $24.715 | +5.3% |
| FY2021 | $23.471 | +4.0% |
| FY2020 | $22.565 | +30.0% |
| FY2019 | $17.362 | +4.3% |
| FY2018 | $16.65 | +4.2% |
| FY2017 | $15.972 | -0.3% |
| FY2016 | $16.023 | +7.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026